We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Aspen Pharmacare is set to receive a long-term funding package of nearly $713m (€600m) to boost the production of Coivd-19 vaccines for countries in the African continent.
Earlier, the same firms were accused and booked for selling Coldbest cough syrup which contained DEG and caused the death of nine children in Jammu and Kashmir.